DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,462,428 | +9.0% | 17,986 | +5.4% | 0.05% | +6.4% |
| Q2 2023 | $4,094,185 | -0.6% | 17,059 | +4.4% | 0.05% | -6.0% |
| Q1 2023 | $4,117,104 | +0.1% | 16,335 | +5.4% | 0.05% | -9.1% |
| Q4 2022 | $4,112,028 | +7.8% | 15,493 | +4.9% | 0.06% | -6.8% |
| Q3 2022 | $3,814,000 | +20.2% | 14,766 | +17.9% | 0.06% | +22.9% |
| Q2 2022 | $3,174,000 | +30.5% | 12,520 | +51.0% | 0.05% | +45.5% |
| Q1 2022 | $2,432,000 | -3.7% | 8,291 | +8.1% | 0.03% | -13.2% |
| Q4 2021 | $2,525,000 | +6.5% | 7,673 | -1.5% | 0.04% | -5.0% |
| Q3 2021 | $2,371,000 | +11.2% | 7,790 | -1.8% | 0.04% | +2.6% |
| Q2 2021 | $2,133,000 | +30.6% | 7,935 | +9.5% | 0.04% | +11.4% |
| Q1 2021 | $1,633,000 | -7.7% | 7,247 | -9.0% | 0.04% | -16.7% |
| Q4 2020 | $1,770,000 | -26.7% | 7,960 | -29.0% | 0.04% | +7.7% |
| Q3 2020 | $2,415,000 | +102.3% | 11,204 | +65.8% | 0.04% | +14.7% |
| Q2 2020 | $1,194,000 | +78.5% | 6,758 | +40.1% | 0.03% | +70.0% |
| Q1 2020 | $669,000 | +53.8% | 4,824 | +69.7% | 0.02% | +100.0% |
| Q4 2019 | $435,000 | +75.4% | 2,842 | +64.8% | 0.01% | 0.0% |
| Q3 2019 | $248,000 | +2.5% | 1,725 | +1.7% | 0.01% | -9.1% |
| Q2 2019 | $242,000 | – | 1,696 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |